Skip to content
LATEST
Health

Global HIV Treatment Access Threatened by Pandemic-Related Supply Chain Disruptions

Pandemic-driven supply chain disruptions threaten HIV treatment access for millions, risking a surge in mortality and stalling progress toward global health…

Global HIV Treatment Access Threatened by Pandemic-Related Supply Chain Disruptions

Seventy-three nations report significant risks of antiretroviral (ARV) medicine stock-outs due to pandemic-related logistics failures. Twenty-four countries currently face critical supply shortages, impacting approximately 8.3 million patients, or one-third of the global population receiving HIV treatment. Modeling suggests that a six-month disruption in access could double AIDS-related mortality in sub-Saharan Africa.

Supply chain instability is attributed to manufacturer delivery failures, restricted air and land transport, and reduced access to domestic health services. While 129 countries have adopted multi-month dispensing policies to mitigate these risks, global progress toward HIV reduction targets has plateaued. New infections have remained stagnant at 1.7 million annually for the past two years.

To address systemic vulnerabilities, health authorities are prioritizing the prequalification of pediatric dolutegravir formulations to improve treatment outcomes for children. Furthermore, new diagnostic guidelines for opportunistic infections, such as histoplasmosis, are being implemented to reduce mortality in immunocompromised populations. Despite these measures, the diversion of resources toward pandemic response continues to jeopardize long-term HIV control objectives.

More stories

Latest news